Efficacy of second generation direct-acting antiviral agents for treatment naïve hepatitis C genotype 1: A systematic review and network meta-analysis

• Main Authors: Suwanthawornkul T., Anothaisintawee T., Sobhonslidsuk A., Thakkinstian A., Teerawattananon Y.
• Other Authors: SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
• Format: Article
• Published: Public Library of Science 2020
• Subjects: antivirus agent; daclatasvir; dasabuvir plus ombitasvir plus paritaprevir plus ritonavir; direct acting antiviral agent; ledipasvir; peginterferon alpha2b plus ribavirin; ribavirin; simeprevir; sofosbuvir; unclassified drug; anemia; Article; drug efficacy; drug safety; fatigue; food and drug administration; hepatitis C; Hepatitis C virus genotype 1; human; meta analysis; risk assessment; systematic review; treatment duration; treatment indication; treatment outcome; treatment response; unspecified side effect; combination drug therapy; genetics; genotype; Hepacivirus; odds ratio; publishing; time factor; virology; virus load; Antiviral Agents; Drug Therapy, Combination; Fatigue; Genotype; Hepatitis C; Humans; Odds Ratio; Publication Bias; Time Factors; Treatment Outcome; Viral Load
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/165756
• Institution: National University of Singapore

10.1371/journal.pone.0145953